New hope for rare kidney cancer: drug combo shows promise in late-stage trial
NCT ID NCT05043090
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 study tests whether combining two drugs (savolitinib and durvalumab) works better than the standard drug sunitinib for people with a rare, advanced kidney cancer called papillary renal cell carcinoma that has a specific genetic change (MET-driven). About 148 adults who have not had prior treatment for their advanced cancer will take part. The main goal is to see how long the cancer stays under control and how long patients live.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Boston, Massachusetts, 02215, United States
-
Research Site
New York, New York, 10065, United States
-
Research Site
CABA, C1426ANZ, Argentina
-
Research Site
Ciudad Autónoma Buenos Aires, 1125, Argentina
-
Research Site
Ciudad de Buenos Aires, C1120AAT, Argentina
-
Research Site
Ciudad de Buenos Aires, C1181ACH, Argentina
-
Research Site
La Plata, 1900, Argentina
-
Research Site
Rosario, S2002KDS, Argentina
-
Research Site
San Miguel de Tucumán, T4000IAK, Argentina
-
Research Site
Box Hill, 3128, Australia
-
Research Site
Macquarie University, 2109, Australia
-
Research Site
Belo Horizonte, 30120-320, Brazil
-
Research Site
Brasília, 70200-730, Brazil
-
Research Site
Cachoeiro de Itapemirim, 29308-065, Brazil
-
Research Site
Criciúma, 88811-508, Brazil
-
Research Site
Curitiba, 81520-060, Brazil
-
Research Site
Florianópolis, 88020-210, Brazil
-
Research Site
Fortaleza, 60130-241, Brazil
-
Research Site
Natal, 59075-740, Brazil
-
Research Site
Pelotas, 96020-080, Brazil
-
Research Site
Porto Alegre, 90020-090, Brazil
-
Research Site
Porto Alegre, 90110-270, Brazil
-
Research Site
Rio de Janeiro, 22250-905, Brazil
-
Research Site
Salvador, 40050-410, Brazil
-
Research Site
São Jose Do Rio Preto, 15090-000, Brazil
-
Research Site
São Paulo, 01246-000, Brazil
-
Research Site
São Paulo, 01327-001, Brazil
-
Research Site
São Paulo, 05652-900, Brazil
-
Research Site
Vitória, 29043-260, Brazil
-
Research Site
Calgary, Alberta, T2N 4N2, Canada
-
Research Site
Montreal, Quebec, H3T 1E2, Canada
-
Research Site
Montreal, Quebec, H4A 3J1, Canada
-
Research Site
Providencia, 7510032, Chile
-
Research Site
Santiago, 7500653, Chile
-
Research Site
Santiago, 8420383, Chile
-
Research Site
Temuco, 4810561, Chile
-
Research Site
Beijing, 100039, China
-
Research Site
Changsha, 410011, China
-
Research Site
Changsha, 410013, China
-
Research Site
Chongqing, 400030, China
-
Research Site
Harbin, 150049, China
-
Research Site
Jinan, 250012, China
-
Research Site
Nanjing, 210029, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shenyang, 110042, China
-
Research Site
Tianjin, 300060, China
-
Research Site
Zhengzhou, 450008, China
-
Research Site
Brno, 625 00, Czechia
-
Research Site
Hradec Králové, 500 05, Czechia
-
Research Site
Olomouc, 775 20, Czechia
-
Research Site
Prague, 100 34, Czechia
-
Research Site
Prague, 140 59, Czechia
-
Research Site
Prague, 15000, Czechia
-
Research Site
Prague, 180 81, Czechia
-
Research Site
Bordeaux, 33075, France
-
Research Site
Quimper, 29107, France
-
Research Site
Toulouse, 31059, France
-
Research Site
Villejuif, 94800, France
-
Research Site
Hamburg, 20246, Germany
-
Research Site
Hanover, 30625, Germany
-
Research Site
München, 81377, Germany
-
Research Site
Ulm, 89081, Germany
-
Research Site
Hong Kong, Hong Kong
-
Research Site
Shatin, 00000, Hong Kong
-
Research Site
Bangalore, 560027, India
-
Research Site
Belagavi, 590010, India
-
Research Site
Jaipur, 302002, India
-
Research Site
Mysore, 570001, India
-
Research Site
Nashik, 422004, India
-
Research Site
Haifa, 91096, Israel
-
Research Site
Petah Tikva, 49100, Israel
-
Research Site
Arezzo, 52100, Italy
-
Research Site
Avellino, 83100, Italy
-
Research Site
Bari, 70124, Italy
-
Research Site
Bologna, 40138, Italy
-
Research Site
Florence, 50134, Italy
-
Research Site
Meldola, 47014, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Naples, 80131, Italy
-
Research Site
Padova, 35128, Italy
-
Research Site
Reggio Emilia, 42123, Italy
-
Research Site
Tricase, 73039, Italy
-
Research Site
Verona, 37134, Italy
-
Research Site
Aguascalientes, 20230, Mexico
-
Research Site
Monterrey, 64460, Mexico
-
Research Site
Querétaro, 76090, Mexico
-
Research Site
Toluca, 50090, Mexico
-
Research Site
Amsterdam, 1105 AZ, Netherlands
-
Research Site
Arnhem, 6815 AD, Netherlands
-
Research Site
Rotterdam, 3045 PM, Netherlands
-
Research Site
Gdansk, 80-952, Poland
-
Research Site
Gdynia, 81-519, Poland
-
Research Site
Krakow, 30-348, Poland
-
Research Site
Otwock, 05-400, Poland
-
Research Site
Poznan, 60-569, Poland
-
Research Site
Cluj-Napoca, 400015, Romania
-
Research Site
Cluj-Napoca, 400641, Romania
-
Research Site
Craiova, 200094, Romania
-
Research Site
Singapore, 169610, Singapore
-
Research Site
Daejeon, 35015, South Korea
-
Research Site
Goyang-si, 10408, South Korea
-
Research Site
Incheon, 405-760, South Korea
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 05505, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
A Coruña, 15006, Spain
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Barcelona, 08036, Spain
-
Research Site
Barcelona, ?08041, Spain
-
Research Site
Córdoba, 14004, Spain
-
Research Site
Madrid, 28034, Spain
-
Research Site
Madrid, 28040, Spain
-
Research Site
Madrid, 28041, Spain
-
Research Site
Majadahonda, 28222, Spain
-
Research Site
Málaga, 29010, Spain
-
Research Site
Pamplona, 31008, Spain
-
Research Site
Seville, 41013, Spain
-
Research Site
Valencia, 46026, Spain
-
Research Site
Kaohsiung City, 83301, Taiwan
-
Research Site
Taichung, 40705, Taiwan
-
Research Site
Tainan, 704, Taiwan
-
Research Site
Adana, 01120, Turkey (Türkiye)
-
Research Site
Ankara, 06100, Turkey (Türkiye)
-
Research Site
Ankara, 06200, Turkey (Türkiye)
-
Research Site
Ankara, 06590, Turkey (Türkiye)
-
Research Site
Cordaleo, 35575, Turkey (Türkiye)
-
Research Site
Edirne, 22030, Turkey (Türkiye)
-
Research Site
Istanbul, 32098, Turkey (Türkiye)
-
Research Site
Istanbul, 34218, Turkey (Türkiye)
-
Research Site
Istanbul, 34722, Turkey (Türkiye)
-
Research Site
Izmir, 35040, Turkey (Türkiye)
-
Research Site
Kazımkarabekir, 01230, Turkey (Türkiye)
-
Research Site
Dnipropetrovsk, 49005, Ukraine
-
Research Site
Leicester, LE1 5WW, United Kingdom
-
Research Site
London, EC1A 7BE, United Kingdom
-
Research Site
London, SW3 6JJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 8,000 kidney tumor samples collected to unlock cancer clues
- Experimental immune cell therapy targets Hard-to-Treat cancers
- New combo shows promise for rare kidney cancers
- Scientists track Cancer's diet in real time during surgery
- Triple-Drug cocktail shows promise for rare kidney cancers
- Head-to-Head drug battle for rare kidney cancer